microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma?
Level V
Where this comes from
- Record sourced from PubMed, PMID 21816909.
- Also identified by DOI 10.1158/1078-0432.CCR-11-1477.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
microRNA-10b (miR-10b) expression in pancreatic ductal adenocarcinoma (PDAC), as identified by in situ hybridization, is highly correlated with cancer diagnosis, therapy response, and prognosis. If these findings are further confirmed in prospective studies, miR-10b could be used to improve the management of PDAC and decrease the mortality rate of this deadly cancer.
Medical subject headings
- Carcinoma, Pancreatic Ductal
- MicroRNAs
- Pancreatic Neoplasms